1. Home
  2. SCYX vs LFS Comparison

SCYX vs LFS Comparison

Compare SCYX & LFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

N/A

Current Price

$4.44

Market Cap

51.4M

Sector

Health Care

ML Signal

N/A

Logo LEIFRAS Co. Ltd. American Depositary Shares

LFS

LEIFRAS Co. Ltd. American Depositary Shares

N/A

Current Price

$2.15

Market Cap

54.2M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
SCYX
LFS
Founded
1999
2001
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
51.4M
54.2M
IPO Year
2014
2024

Fundamental Metrics

Financial Performance
Metric
SCYX
LFS
Price
$4.44
$2.15
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
64.8K
93.8K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
61.36
N/A
EPS
N/A
N/A
Revenue
$257,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$608.78
N/A
P/E Ratio
N/A
$25.19
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$1.58
52 Week High
$6.09
$12.49

Technical Indicators

Market Signals
Indicator
SCYX
LFS
Relative Strength Index (RSI) 38.72 42.94
Support Level $0.67 $2.11
Resistance Level $5.56 $2.33
Average True Range (ATR) 0.34 0.08
MACD -0.12 -0.01
Stochastic Oscillator 0.63 10.64

Price Performance

Historical Comparison
SCYX
LFS

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About LFS LEIFRAS Co. Ltd. American Depositary Shares

Leifras Co Ltd is a sports and social business company dedicated to youth sports and community engagement. It provide services related to the organization and operations of sports schools and sports events for children. The company focuses on covering 13 sports like soccer, basketball, and dance and in child athletic development, club activity management for schools, and social businesses like elderly care.

Share on Social Networks: